Want to see HK:0189 full AI Analyst Report?
0189 Stock Chart & Stats
HK$10.86
HK$0.24(2.97%)
At close: 4:00 PM EST
HK$10.86
HK$0.24(2.97%)
Day’s Range― - ―
52-Week RangeHK$9.42 - HK$23.74
Previous CloseN/A
Volume24.83M
Average Volume (3M)14.24M
Market Cap
HK$22.39B
Enterprise ValueHK$32.62K
Total Cash (Recent Filing)HK$5.02B
Total Debt (Recent Filing)HK$33.81M
Price to Earnings (P/E)9.6
Beta0.75
Next Earnings
Mar 30, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.43%
Share Statistics
EPS (TTM)0.98
Shares Outstanding1,732,711,700
10 Day Avg. Volume20,413,382
30 Day Avg. Volume14,237,343
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.13
Price to Sales (P/S)1.13
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$21.67Price Target Upside99.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.49
Revenue Forecast (FY)HK$16.78B
Bulls Say, Bears Say
Bulls Say
Very Low LeverageExceptionally low debt reduces financial risk and interest burden, preserving flexibility to fund capacity, research, or shareholder returns through industry downturns. The strong equity base also provides durable downside protection.
Profitability ReboundThe sharp recovery in gross, operating, and net margins indicates improved earnings power versus 2023–2024. If product mix, pricing, and cost discipline persist, stronger margins can support reinvestment and cash generation.
Improved Cash GenerationThe 2025 improvement shows better conversion of operations into cash and increases the company’s capacity to finance capital needs internally. This reduces reliance on external funding while supporting investment and potential shareholder distributions.
Bears Say
Weak Revenue GrowthLimited top-line expansion constrains operating leverage and makes future profit improvement more dependent on pricing, mix, or cost reductions. Sustained weak revenue growth could reduce the group’s ability to compound earnings across its product markets.
Cyclical EarningsExposure to cyclical fluorochemical and silicone markets creates meaningful swings in demand, pricing, and profitability. This volatility makes earnings less predictable and can pressure utilization, margins, and investment returns during industry downturns.
Uneven Free Cash FlowThe history of negative or weak free cash flow shows that strong 2025 cash generation has not yet demonstrated consistency across the cycle. Uneven conversion can complicate reinvestment planning and reduce confidence in recurring shareholder returns.
Dongyue Group Limited News
0189 FAQ
What was Dongyue Group Limited’s price range in the past 12 months?
Dongyue Group Limited lowest stock price was HK$9.42 and its highest was HK$23.74 in the past 12 months.
What is Dongyue Group Limited’s market cap?
Dongyue Group Limited’s market cap is HK$22.39B.
When is Dongyue Group Limited’s upcoming earnings report date?
Dongyue Group Limited’s upcoming earnings report date is Mar 30, 2027 which is in 217 days.
How were Dongyue Group Limited’s earnings last quarter?
Dongyue Group Limited released its earnings results on Aug 20, 2026. The company reported HK$0.7 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Dongyue Group Limited overvalued?
According to Wall Street analysts Dongyue Group Limited’s price is currently Undervalued.
Does Dongyue Group Limited pay dividends?
Dongyue Group Limited pays a Annually dividend of HK$0.3 which represents an annual dividend yield of 2.43%. See more information on Dongyue Group Limited dividends here
What is Dongyue Group Limited’s EPS estimate?
Dongyue Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dongyue Group Limited have?
Dongyue Group Limited has 1,732,711,700 shares outstanding.
What happened to Dongyue Group Limited’s price movement after its last earnings report?
Dongyue Group Limited reported an EPS of HK$0.7 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.565%.
Which hedge fund is a major shareholder of Dongyue Group Limited?
Currently, no hedge funds are holding shares in HK:0189
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dongyue Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$21.67 (99.54% Upside)
HK$21.67 (99.54% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.99%
12-Months-Change
Fundamentals
Return on Equity
2.43%
Trailing 12-Months
Asset Growth
17.76%
Trailing 12-Months
Company Description
Dongyue Group Limited
Dongyue Group Limited functions as an investment holding company, primarily engaged in the production, distribution, and sale of a diverse range of chemical substances. Operating predominantly within the People's Republic of China, its core product offerings include polymers, organic silicones, refrigerants, and industrial chemicals such as dichloromethane, polyvinyl chloride (PVC), and liquid alkali. The company's operations are segmented into distinct divisions: Polymers, Refrigerants, Organic Silicone, Dichloromethane/PVC and Liquid Alkali, Property Development, and Other Operations. Its comprehensive chemical portfolio extends to fluoride fine chemicals, various chloride and alkali compounds, fluoride salt and acid products, polytetrafluoroethylene, methane chloride, anhydrous fluoride, fluorite, silicon rubber, fluoropolymers, ammonium bifluoride, hydrofluoric acid, and bromine derivatives. Beyond its core chemical manufacturing, Dongyue also participates in residential property development and provides environmental services, specifically sewage treatment and monitoring. While its headquarters are located in Zibo, People's Republic of China (where it was established in 1987), the Group maintains a significant international footprint, conducting business across numerous countries including Japan, South Korea, India, Singapore, Thailand, the United Arab Emirates, Pakistan, Malaysia, Kuwait, Saudi Arabia, Indonesia, Israel, the Philippines, Vietnam, and Turkey, among other global markets.
0189 Stock 12 Month Forecast
Average Price Target
HK$21.67
▲(99.54% Upside)
Technical Analysis
China Risun Group Ltd.
―
Tiande Chemical Holdings Limited
―
Dongguang Chemical Ltd.
―
China Sanjiang Fine Chemicals Co., Ltd.
―
Global New Material International Holdings Limited
―







